Enter Semaglutidea GLP-1 receptor agonistoriginally developed to control blood sugar and support weight loss
So strength training, we've gotta combat sarcopenic obesity, whether on GLP ones or not, you're gonna lose muscle
However, although angiotensin-converting enzyme inhibitors are effective, they need to be stopped in many patients due to adverse events, including symptomatic hypotension, kidney failure, cough, diarrhea, and dizziness
Understanding the link between semaglutide and GERD is important for patients who want to manage their weight while avoiding discomfort
To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation